Sumitomo Dainippon Pharma Co Ltd - Net Income Applicable To Common Shares

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Net-Income-Applicable-To-Common-Shares" stands at 154.72 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Sumitomo Dainippon Pharma Co Ltd's second quarter result of 87.65 Billion JPY for the item "Net Income Applicable To Common Shares" represents an increase of 682.21 percent compared to it's first quarter result.

Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of 87.65 Billion JPY for the item "Net Income Applicable To Common Shares" represents an increase of 281.98 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of 154.72 Billion JPY for the item "Net Income Applicable To Common Shares" represents an increase of 718.51 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 434.18 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 434.18 Billion Japanese Yens.
The 3 year change is 142.04 Billion Japanese Yens.
The 5 year change is 107.00 Billion Japanese Yens.
The 10 year change is 137.82 Billion Japanese Yens.

The Serie's long term average value is 1.46 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 153.26 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +469.69 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0 Billion.